Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)

NCT00431041 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: solifenacin
DRUG: oxybutynin immediate release

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]